u/UnfairRazzmatazz987 · 28d agono track record yet
CMPS to $40 Is Starting to Look Very Real
CMPS is positioned to become a leader in psychedelic medicine with COMP360 in Phase 3 for treatment-resistant depression and FDA breakthrough therapy designation. Approval would unlock a massive new treatment category, making $40 a realistic target that still undervalues the company's market opportunity.
At post $10.96Now $11.03+0.6% since postedas of Jun 10, 4:59 PM ET
1d-3.1%
3d-5.4%
1w-0.8%
1m—
3m—
6m—
1y—